Influenza virus, primarily type A and type B, is responsible for human epidemics causing worldwide morbidity and mortality.1 Respiratory syncytial virus is a leading cause of lower respiratory tract infections and hospitalizations in infants and children,2 and is associated with a substantial disease and health economic burden in older adults.3
Prompt and accurate detection of influenza and RSV infections can help target the use of antivirals, reduce inappropriate antibiotic use and unnecessary hospitalization.
The cobas® Influenza A/B & RSV UC Test for use with the cobas omni Utility Channel on the cobas® 6800/8800 Systems is a high-throughput multiplex assay for the qualitative detection and differentiation of respiratory viruses Influenza A, Influenza B and RSV.
Run fully compliant, CE-IVD workflow without further optimization. Positive and negative controls included.
Benefit from fully automated cobas® 6800/8800 Systems and an industry-leading menu to tackle seasonal high demand.
Centers of Disease Control and Prevention. Understanding Influenza Viruses. https://www.cdc.gov/flu/about/viruses/index.htm. Accessed 15 June 2021.
Smith DK, Seales S, Budzik C. Respiratory Syncytial Virus Bronchiolitis in Children. Am Fam Physician. 2017;95(2):94-99.
Ackerson B, Tseng HF, Sy LS, et al. Severe Morbidity and Mortality Associated With Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older Adults. Clin Infect Dis. 2019;69(2):197-203. doi:10.1093/cid/ciy991.
Test performanceView Full Table
|Test results||Agreement Statistics|
|Virus||Number of Samples||Concordant Positive (N)||Discordant Positive (N)||Concordant Negative (N)||Discordant Negative (N)||Agreement Parameter||Percent Agreement (%)||95% CI (LCL, UCL)*|
|Influenza A||377||91||6||280||0||PPA||100.0%||(95.9%, 100.0%)|
|Inluenza B||377||85||4||287||1||PPA||98.8%||(93.7%, 99.8%)|
Key ParametersView Full Table
|Targets||Influenza A, influenza B, respiratory syncytial virus|
|Sample and media types||Nasopharyngeal swab samples collected in the Copan UTM-RT® System, the BD™ UVT System or equivalent|
|Minimum amount of sample required||0.6 mL|
|Sample processing volume||0.4 mL|
|Test duration||Results are available within less than 3.5 hours after loading the sample on the system|
|System software||cobas® 6800/8800 System Software 1.4 or higher|